Insider Transactions in Q4 2025 at Eton Pharmaceuticals, Inc. (ETON)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2025
|
James R. Gruber Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,542
-2.06%
|
$72,672
$16.99 P/Share
|
|
Dec 12
2025
|
David Krempa Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,264
-0.98%
|
$106,488
$17.0 P/Share
|
|
Dec 12
2025
|
Ipek Erdogan Trinkaus Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85
-3.42%
|
$1,360
$16.9 P/Share
|
|
Dec 12
2025
|
Sean Brynjelsen President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,732
-0.23%
|
$107,712
$16.83 P/Share
|